Primary infection in the neonate, especially group B streptococcal infection, has long been recognized as a cause of persistent pulmonary hypertension of the newborn (PPHN), sometimes requiring treatment with inhaled nitric oxide (iNO) and extracorporeal membrane oxygenation (ECMO). However, secondary nosocomial infections in the neonatal period have not been widely reported as a cause of severe recurrent pulmonary hypertension (PHTN). We now present two cases of secondary infection in the neonate leading to significant PHTN. In both cases, the infants presented with PPHN soon after birth, requiring transfer to a level 3 neonatal intensive care unit and treatment with high-frequency oscillatory ventilation and iNO. After successful resolution of the initial PPHN, including extubation to nasal cannula, both infants developed signs of severe recurrent PHTN, leading to reintubation, high-frequency oscillatory ventilation and iNO therapy, and consideration of ECMO. In both cases, blood cultures taken at the time of recurrence of PHTN returned positive, one for Staphylococcus epidermidis, the other for methicillinresistant Staphylococcus aureus. These unusual cases present the possibility of severe recurrent PHTN requiring iNO or ECMO in the setting of secondary infection. We speculate that these infants, although extubated after their first episodes of PHTN, were at risk for recurrence of PHTN due to continued pulmonary vascular reactivity.
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Persistent pulmonary hypertension of the newborn (PPHN) continues to be a challenging and life-threatening condition despite advances in therapy such as high-frequency oscillatory ventilation (HFOV), surfactant therapy, inhaled nitric oxide (iNO), and extracorporeal membrane oxygenation (ECMO). Many cases are idiopathic, but a number of associated conditions, including infectious etiologies, have been identified. Shankaran et al. 1 reported five cases of documented PPHN in association with B-hemolytic group B streptococcal infection and one case of PPHN associated with group A streptococcal infection. In 1989, Girardin et al. 2 presented a case of neonatal listeriosis, diagnosed by gastric aspirate and blood culture, in which the infant developed significant and subsequently fatal PPHN. The authors also found that serum tumor necrosis factor-␣ levels were extremely elevated; a role for cytokines was thereby suggested in the pathogenesis of clinical shock and PPHN in this infection. Goulin et al. 3 reported on three infants with pulmonary hypertension (PHTN) associated with Bordetella pertussis infection, which developed after hospital discharge and was fatal in all cases. Finally, Ng et al. 4 reported a case of congenital cytomegalovirus infection presenting as severe PPHN and ultimately leading to refractory hypoxemia and death at 15 days of age.
Recurrent PHTN in the newborn has been less widely reported. In the neonatal population, alveolar capillary dysplasia has been reported as a cause of recurrent PHTN after ECMO. 5 Recurrent PHTN in patients with congenital diaphragmatic hernia after ECMO therapy has also been reported and can be fatal. 6 Successful treatment of recurrent PHTN in some patients has been reported with HFOV and iNO, 7 although the pathophysiology of this response is still being debated. 8 Recurrent or secondary infections in the high-risk neonate are frequently seen and have been presented in the literature. 9, 10 However, recurrent PHTN due to a secondary infection in the neonatal population has not, to our knowledge, been reported. We now present two cases of infants who initially presented to the neonatal intensive care unit with PPHN but later had culture-proven secondary infection associated with significant recurrent PHTN.
CASE 1
Baby Girl H was born at 40 and 3/7 weeks' gestation to a 33-year-old, gravida 1, para 0, group B streptococcal-negative woman at an outside hospital. Amniotic fluid was initially clear, but at the time of delivery, it was slightly meconium stained. The infant had Apgar scores of 6 and 8 at 1 and 5 minutes, respectively. However, almost immediately on delivery, the infant began having grunting and flaring and required blow-by O 2 . The infant was taken to the nursery, where oxygen by hood was administered. An arterial line was placed, sepsis evaluation was begun, and ampicillin and gentamicin were started. Initial arterial blood gas revealed a pH of 7.2, PACO 2 of 52 mm Hg, and PAO 2 of 234 mm Hg. Over the next 2 days, the infant deteriorated with oxygenation difficulties, culminating in a requirement for
a chest tube due to a right pneumothorax. She was transferred to a level 3 neonatal intensive care unit. On transfer on day of life (DOL) 3, the infant was intubated and placed on HFOV and iNO at 30 parts per million, which resulted in a PAO 2 of 100 to 150 mm Hg. On DOL 9, the infant was weaned off iNO and was placed on a conventional ventilator on DOL 10. She was extubated to nasal cannula (0.1 l at FIO 2 of 0.35) on DOL 11, and plans were made to attempt feeding.
On DOL 12, Baby Girl H had repeated episodes of cyanosis and required reintubation. She required vigorous fluid resuscitation for poor perfusion and, due to an oxygenation index of Ͼ30, reinitiation of iNO at 30 parts per million to achieve a PAO 2 of 130 to 150 mm Hg. White blood cell count at that time was 13,600, with 53% segmented neutrophils and 12% bands. Echocardiogram revealed severe PHTN with right to left shunting across the patent foramen ovale, and low cardiac volume. Finally, dopamine, bicarbonate, and prostaglandin E 1 infusions were required. Transfer to our ECMO center with continuation of iNO on conventional ventilator settings of peak inspiratory pressure at 34, positive end-expiratory pressure at 6, intermittent mandatory ventilation at 70, and FIO2 at 1.0 was arranged on DOL 13. Before transfer, vancomycin and cefotaxime were started.
On admission to our institution, chest x-ray revealed streaky infiltrates bilaterally with right middle lobe consolidation. iNO was decreased to 20 parts per million, and ventilatory pressures were weaned. Oxygenation indexes remained in the 10 to 14 range during the first hours at our institution and dropped further to the 4 to 8 range over the next 12 to 24 hours. A blood culture drawn on admission to our institution grew Staphylococcus epidermidis in Ͻ1 day. The C-reactive protein level reached a peak of 9.7 on DOL 15.
Over the next 3 days, the infant was weaned to FIO 2 at 0.36 and was weaned off iNO on DOL 17. She was extubated on DOL 19, and slow feeds were started the same day. Vancomycin was discontinued after a full 10-day course, and after C-reactive protein returned to a normal level. She was discharged from the hospital on DOL 25.
CASE 2
Baby Boy T was a term infant born by repeat cesarean section at an outside hospital to a 38-year-old gravida 5, para 2 woman after rupture of membranes for 25 1/2 hours and fever to 100.9°F
. The mother was pretreated with clindamycin for diagnosis of chorioamnionitis, and fetal tachycardia was noted. Apgar scores were 7 and 9 at 1 minute and 5 minutes, respectively. Due to respiratory distress in the delivery room, the infant was taken to the neonatal intensive care unit for observation, where he required increasing FIO 2 by nasal cannula and hood, progressing to continuous positive airway pressure and finally intubation. Sepsis evaluation was undertaken; his white blood cell count was 9800/mm 3 without left shift, and ampicillin and gentamicin were started. The infant had extremely labile PAO 2 s from 40 to 300 mm Hg, beractant (Survanta; Ross Pharmaceuticals, Columbus, OH) was given, and HFOV was instituted. Volume resuscitation, dopamine and dobutamine infusions, and bicarbonate infusions were required. Echocardiogram revealed PHTN but no intracardiac anomalies. Transfer to our ECMO center was arranged on DOL 2 on HFOV settings of mean airway pressure at 22 cm H 2 O, amplitude at 30, and FIO 2 at 1.0. Due to continued hypotension, an epinephrine infusion was initiated. Head ultrasound was negative. iNO was started after the oxygenation index had reached Ͼ25 and informed consent had been obtained, and was increased to 20 parts per million per protocol. Over the next 2 days, the patient remained pH and blood pressure sensitive; two echocardiograms during that time revealed continued elevated right ventricular pressures by Doppler profile. C-reactive protein rose to 5.1 on DOL 3, although blood cultures were negative; therefore, ampicillin and gentamicin were continued for 7 full days. On DOL 6, the infant was changed to conventional ventilation, and he was weaned off of iNO on DOL 7. Acyclovir was started after electroencephalogram revealed bilateral temporal lobe spikes with moderate encephalopathy, but cerebrospinal fluid polymerase chain reaction for herpes simplex virus later returned negative. The infant was transferred back to the referring institution on DOL 9 on ventilator settings of 19/5, synchronized intermittent mandatory ventilation 20, and FIO 2 0.3. Before transfer, the infant had a repeat echocardiogram that revealed no evidence of PHTN.
Over the next 2 days, the patient was weaned to nasal cannula and started small feeds. On DOL 11, the infant developed respiratory distress, with an arterial blood gas that revealed a pH of 7.17, PACO 2 of 40 mm Hg, PAO 2 of 69 mm Hg, and bicarbonate at 14; fluid resuscitation and bicarbonate infusions were initiated. Subsequent arterial blood gases revealed continuing acidosis, and the infant was intubated. Blood culture was drawn, and vancomycin and cefotaxime were started. Later, however, the infant began to have frank blood per endotracheal tube. Ventilator settings were increased, the infant was paralyzed, epinephrine was given through an endotracheal tube, dopamine infusion was started, and blood products were infused. Echocardiogram revealed PHTN and poor right ventricular function. The infant was again transferred to our ECMO facility on DOL 12.
On arrival, the infant was placed on HFOV with mean airway pressure at 24, amplitude at 56, and FIO 2 at 1.0; chest x-ray revealed hazy fields bilaterally. After informed consent had been obtained, iNO was initiated, but O 2 saturations remained in the 60% range. The infant was prepped for ECMO; veno-venous and veno-arterial cannulation attempts were unsuccessful, however, due to extremely small vessels. Saturations improved on iNO during the cannulation attempt; therefore, the infant was continued on HFOV and iNO. Due to the unusual clinical presentation, a cardiac catheterization was undertaken that was normal. Over the next few days, the patient was weaned from HFOV on DOL 15 and from iNO on DOL 17. He was extubated on DOL 21 and weaned to room air on DOL 23. The blood culture drawn before the second transfer to our institution grew methicillin-resistant Staphylococ-cus aureus, for which he received 14 days of vancomycin. He was discharged to home on DOL 42.
DISCUSSION
These two unusual cases present the possibility of severe recurrent PHTN, requiring iNO or ECMO, in association with secondary infection. However, it would not be unlikely to expect PHTN to present as part of a secondary infection episode, given the fact that it is a prominent feature of laboratory models of early sepsis. 11 Indeed, PHTN is an extremely reproducible finding in animal models of early group B streptococcal sepsis, with pulmonary artery pressure rising within 5 minutes of instituting the sepsis protocol, as reported by Meadow and Meus. 12 and Philips et al. 13 Thromboxane A 2 has been shown in the laboratory, through observation of effects on pulmonary artery pressure after administration of thromboxane agonists and antagonists, to be responsible for early sepsis-induced PHTN. 14, 15 However, PHTN occurs later in sepsis models, even if the effects of thromboxane are blocked. It has been suggested that this is due to tumor necrosis factor-mediated lung tissue damage, 16 which may be responsible for findings such as pulmonary edema and increased concentrations of serum protein present in lung lymph fluid. 17 These later effects appear to exacerbate the already deleterious effects of increased PHTN. Worsening of ventilation-perfusion matching, increased mean airway pressure required to ventilate a noncompliant lung, and increasing resistance and associated decreasing cardiac output, all may lead to worsening hypoxic injury. This, in turn, may lead to further myocardial function abnormalities, making both cardiac output and pulmonary blood flow even worse.
Recurrent PHTN has been recognized as a significant problem, but not with secondary infection. Repeat ECMO cannulations are possible, but are technically challenging, and the majority of those cases have been due to recurrent PHTN in congenital diaphragmatic hernia patients, or for later diagnosed cardiac or irreversible pulmonary anomalies. 18 In this patient population, the outcome is usually extremely guarded. A second course of ECMO due to infectious causes has been reported by Dela Cruz et al. 19 in an infant who developed necrotizing tracheobronchitis. iNO has likely led to a decreased need for repeat ECMO cannulation, even in the setting of secondary infection in which blood pressure instability may, in fact, be a central component of the clinical decompensation.
In summary, we have presented two cases of recurrent PHTN associated with culture-proven secondary infection. We submit that secondary infection in the critically ill neonate may be a heretofore unrecognized cause of significant recurrent PHTN leading to repeat treatment with iNO or ECMO. In addition to research evidence supporting the significant early PHTN and later pulmonary edema in models of infection, we suggest that, with previous evidence of PPHN, increased pulmonary vascular reactivity may put these patients at higher risk for significant recurrent PHTN due to secondary infection.
